| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.043 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |